Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian High Grade Serous Adenocarcinoma 1 Medulloblastoma 1 Locally Advanced Non-Small Cell Lung Cancer 1 Leukemia, Myeloid, Acute 1 Hypoxia 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 35 Temozolomide 33 Filgrastim 26 Etoposide 26 Carboplatin 25 Vincristine 22 Cisplatin 22 Radiotherapy 20 Magnetic Resonance Spectroscopy 18 Thiotepa 14 Irinotecan 13 Granulocyte Colony-Stimulating Factor 12 Peripheral Blood Stem Cell Transplantation 11 Lomustine 11 Specimen Handling 9 Radiation 9 Melphalan 9 etoposide phosphate 8 Topotecan 8 Methotrexate 8 X-Rays 7 Platinum 7 Phantoms, Imaging 7 sonidegib 6 Biopsy 6 1,2-diaminocyclohexaneplatinum II citrate 6 sargramostim 5 palbociclib 5 Nuclear Medicine Department, Hospital 5 HhAntag691 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Atovaquone × Clear all

NCT06624371 2025-07-22

AflacBT2303

Emory University

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡